Digital Pathology Market by Product, Type, Application and Forecast by 2023

The global digital pathology market is projected to showcase extensive growth during the forecast period, mainly due to increasing adoption of digital pathology products to improve the efficiency of laboratories across the globe, and rising government initiatives in collaboration with market players to raise awareness about the advanced digital pathology products and technologies.

Browse report sample at: https://www.psmarketresearch.com/market-analysis/digital-pathology-market/report-sample

Pharmaceutical and biotechnology companies, hospitals and clinics, and academic institutes and research laboratories are the key end users of digital pathology globally. Pharmaceutical and biotechnology companies as an end-user category is expected to hold the largest share in the digital pathology market, as these companies utilize digital pathology for various activities, such as biopharmaceutical studies, biobanking, and molecular assays.

Geographically, North America is expected to be the largest contributor in the digital pathology industry in the coming years, owing to increasing prevalence of chronic diseases, growing healthcare expenditure, and increasing government initiatives in collaboration with market players in diagnostic field.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=digital-pathology-market

However, the market in Asia-Pacific is expected to witness the highest growth in demand during the forecast period. This is mainly due to the rapid economic growth, growing pharmaceutical and biotechnology industry, strong presence of small and medium-sized pharmaceutical and biotechnology companies, and increasing government initiatives to raise awareness about digital pathology in the region.

Integration of laboratory information system (LIS) with digital pathology system (DPS) is expected to boost the adoption of digital pathology system and act as a potential opportunity for the market players to increase their revenue by providing installation and implementation services that integrates both LIS and DPS. Many laboratories are making efforts towards the integration of these systems, which, in turn, should help streamline digital sign-out workflow, minimize unnecessary and error-prone manual work, and reduce delivery cost of glass slides.

Browse report at: https://www.psmarketresearch.com/market-analysis/digital-pathology-market

Key market players in the digital pathology industry are introducing new digital pathology solutions. For instance, in March 2018, F. Hoffmann-La Roche AG launched VENTANA DP 200 high speed slide scanner for digital pathology. The tray-based design of this scanner is able to produce high-quality images.

Furthermore, in October 2017, Applied Spectral Imaging (ASI), launched PathFusion and HiPath Pro imaging; Brightfield and FISH imaging and analysis solutions for pathology, in order to provide advanced diagnostic services to patients.

Some of the other players in the digital pathology market include Danaher Corporation, Koninklijke Philips N.V., Hamamatsu Photonics, 3DHISTECH Ltd, Apollo Enterprise Imaging Corporation, XIFIN Inc., Huron Digital Pathology, Visiopharm A/S, Corista, and Indica Labs.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact: P&S Intelligence Toll-free: +1-888-778-7886 (USA/Canada) International: +1-347-960-6455 Email: enquiry@psmarketresearch.com Web: https://www.psmarketresearch.com